Carticel for Cartilage Repair
The FDA has approved new labeling for autologous cultured chondrocytes (Carticel, Genzyme). The label incorporates data from the Study of the Treatment of Articular Repair (STAR), which investigated patients who responded inadequately to a previous cartilage repair procedure of the knee.
Approved in 1995, Carticel is used by orthopedic surgeons to treat articular cartilage lesions on the thighbone part of the knee caused by trauma that have not responded to previous repair surgery. Carticel was the first cell therapy to be approved by the FDA.
lansoprazole 30 mg
